• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

grant.mcarthur@unimelb.edu.au

Credentials


Position
The Lorenzo Galli Chair in Melanoma & Skin Cancers
Melbourne Medical School - Admin
Education
PhD
University of Melbourne
Bachelors Degree (Honours)
Monash University
Bachelors Degree
University of Melbourne
ORCID

0000-0001-8908-6071

Prof Grant McArthur

The Lorenzo Galli Chair in Melanoma & Skin Cancers
Melbourne Medical School

660 Scholarly works
40 Projects

HIGHLIGHTS

  • 2026

    Research grants (ARC, NHMRC, MRFF)

    Improving Outcomes for Patients With Melanoma
  • 2023

    Journal article

    Designing a wholly online, multidisciplinary Master of Cancer Sciences degree
    DOI: 10.1186/s12909-023-04537-1
  • 2020

    Research Grant

    ProTreat: An Adaptive and Rapid Implementation Trial of Novel Therapies to Prevent and Treat COVID19 Infection in High Risk Cancer Patients
  • 2017

    Research grants (other domestic)

    Novel Approaches for Overcoming Resistance to Therapies for Advanced Melanoma
  • 2014

    Journal article

    Bioinformatics pipelines for targeted resequencing and whole-exome sequencing of human and mouse genomes: A virtual appliance approach for instant deployment
    DOI: 10.1371/journal.pone.0095217
  • 2014

    Journal article

    Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis
    DOI: 10.1158/2159-8290.CD-13-0440
  • 2013

    Journal article

    Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumours
    DOI: 10.1038/srep03494
Grant McArthur

Latest Honours,
Awards and Fellowships


1995
Fellow of the Royal Australasian College of Physicians (FRACP)

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    Tumor-resident T cells and dendritic cells form an in situ archetype during immunotherapy response in melanoma.
    DOI: 10.1038/s41467-026-74076-y
  • 2026

    Journal article

    Real world outcomes of neoadjuvant immune checkpoint blockade (ICB) for resectable stage III melanoma: Pathologic response and FDG PET/CT correlates.
    DOI: 10.1200/jco.2026.44.16_suppl.9569
  • 2026

    Journal article

    Phase 1b study of a brain-penetrant MEK inhibitor, PF-07799544, plus next-generation BRAF dimer inhibitor, PF-07799933, in advanced BRAF -mutant melanoma.
    DOI: 10.1200/jco.2026.44.16_suppl.9512
  • 2026

    Journal article

    Closing the distance and the Specialist Nursing Optimal Placement Tool (SN-OPT): Strategic placement of specialist cancer nurses to achieve resource and geographic equity in Australia.
    DOI: 10.1200/jco.2026.44.16_suppl.11082
  • 2026

    Journal article

    A Framework for MRI Characterization of Intracranial Metastatic Disease
    DOI: 10.1148/rycan.250627
  • 2026

    Journal article

    Abstract 1215: Spatial transcriptomic analysis of primary melanomas with extreme clinical outcomes.
    DOI: 10.1158/1538-7445.am2026-1215
  • 2026

    Journal article

    CP-GEP identifies high-risk T1a melanoma patients beyond established adverse features
    DOI: 10.1016/j.jaad.2025.10.036
  • 2026

    Journal article

    Current and emerging opportunities for deintensification of systemic therapies in melanoma: A scoping review
    DOI: 10.1016/j.ejca.2025.116132

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224